Today's News | Note: News feeds may no longer be available for the articles on this page.

Swine flu drug sales soar amid stockpiling 9:33 AM 7/22/2009
CNN - USA
Glaxo said that by the end of the year annual production capacity for Relenza Diskhaler inhaler and Rotacaps will be 190 million treatment courses. More than 3 times the previous capacity. ...

Epix Pharmaceuticals is latest biotech to fall 5:11 AM 7/22/2009
Boston Globe - United States
Epix Pharmaceuticals Inc confirmed it was moving ahead with "an orderly liquidation’’ of its assets. Biopure Corp filed for Chapter 11 bankruptcy last week. ...

P&G in Talks With Several Parties to Sell Drug Business 4:31 AM 7/22/2009
Wall Street Journal - USA
Procter & Gamble Co is getting closer to a possible sale of its prescription-drug business. Warner Chilcott Ltd and private-equity firm Cerberus Capital Management LP may be interested. ...

Costly Drugs Known as Biologics Prompt Exclusivity Debate 3:32 AM 7/22/2009
New York Times - United States
Biogen Idec’s Avonex, Genentech’s Avastin, and several Genzyme drugs cost tens to hundreds of thousands of dollars per year. Complex proteins made by living cells. Hard to copy. Unlikely there will be significant savings with a biogeneric. ...

Sucampo, Takeda bowel-drug study shows mixed data 1:11 AM 7/22/2009
Reuters - USA
Sucampo Pharmaceuticals Inc and Takeda Pharmaceutical said two late-stage trials of their experimental drug lubiprostone for opioid-induced bowel dysfunction (OBD) showed mixed results. ...

J&J May End Up as Elan's Partner on Tysabri MS Drug 10:12 AM 7/21/2009
Bloomberg
Johnson & Johnson might become Elan Corp’s partner on the multiple sclerosis drug Tysabri in the event Biogen Idec Inc is acquired. ...

FDA fast tracks Spectrum, Allergan cancer drug 9:22 AM 7/21/2009
Forbes
Spectrum Pharmaceuticals Inc and Allergan Inc said the US FDA will grant a faster review to their drug candidate EOquin intended to treat non-muscle invasive bladder cancer. ...

Incyte reaches agreement with FDA on drug trial 7:32 AM 7/21/2009
Reuters
The trial, named COMFORT-I, will compare the efficacy and safety of the drug, INCB18424, with a dummy drug in about 240 patients with different kinds of ...

US approves Novartis blood pressure combo drug 5:31 AM 7/21/2009
Reuters
The US FDA approved Novartis AG's Tekturna HCT combination as an initial treatment for patients who are unlikely to respond sufficiently to aliskiren alone. ...

FDA accepts Spectrum's response on cancer drug 7:13 AM 7/20/2009
Reuters - USA
Spectrum Pharmaceuticals Inc said that the US FDA accepted for review the company's response on its experimental cancer drug Zevalin. ...

Alnylam, Cubist say lung drug meets main goal 7:10 AM 7/20/2009
Reuters - USA
Alnylam Pharmaceuticals and Cubist Pharmaceuticals said a mid-stage study of their experimental inhaled drug ALN-RSV01 to treat respiratory syncytial virus (RSV) infection over 90 days after treatment in lung-transplant patients met the main goal. ...

Affymax: independent committee positive on anemia drug 7:05 AM 7/20/2009
Reuters - USA
Affymax Inc said an independent data monitoring committee recommended the continuation of the company's late-stage trials of its experimental Hematide drug to treat anemia in chronic renal failure patients. ...

Human Genome soars as lupus drug succeeds in trial 6:58 AM 7/20/2009
Washington Business Journal - USA
Human Genome Sciences Inc scored a major win with positive results from its experimental Benlysta lupus drug being developed with GlaxoSmithKline. ...

Orexigen Reports Success In Obesity Drug Trials 6:00 AM 7/20/2009
Wall Street Journal - USA
Orexigen Therapeutics Inc said its Contrave drug showed strong results in three large late-stage studies treating obesity. ...

Nycomed submits Daxas lung drug for US approval 5:20 AM 7/20/2009
Reuters - USA
Nycomed has filed its Daxas "smokers lung" drug for marketing approval in the US. Nycomed has filed Daxas for approval in the European Union. ...

<- Day Earlier | Today's News